Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice

Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice

ABSTRACT Background Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) are established treatment options for type 2 diabetes (T2D). In addition to their glycemic benefit, GLP‐1 RAs also induce weight loss by suppressing appetite via hypothalamic pathways. However, it remains unclear whether weigh...

Full description

Saved in:
Bibliographic Details
Main Authors: Marwa Al‐Badri, Shilton Dhaver, Osama Hamdy
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Journal of Diabetes
Subjects:
GLP‐1 receptor agonists
glycemic control
real‐world clinical practice
type 2 diabetes
weight loss
Online Access:https://doi.org/10.1111/1753-0407.70054
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items